IL6 and hepatocellular carcinoma: Additionally, the induction of regulatory DCs generation by hepatic carcinoma-associated fibroblasts is also associated with IL-6-mediated STAT3 activation; regulatory DCs produce indoleamine 2,3-dioxygenase, which inhibits T cell function and promotes Treg expansion, exerting immunosuppressive effects [53].